MAPT and supranuclear palsy, progressive, 1: Unlike 18F-flortaucipir, which exhibits off-target binding and does not correlate with long-term PSPRS scores, 18F-PI-2620 distinguishes PSP from AD (cortical tau) and PD (no tau) with AUC ~ 0.90 [105].